We Salvavidas Pharmaceutical Pvt Ltd are a leading Manufacturer and Exporter of CIMIVIR L TABLET (Sofosbuvir 400mg + Ledipasvir 90mg ) in different strength and packing. Our manufacturing facility is certified with WHO-GMP.
CIMIVIR L TABLET (Sofosbuvir 400mg + Ledipasvir 90mg )
Brand name:CIMIVIR L
Active Ingeridents(Generic Name) : Sofosbuvir 400mg + Ledipasvir 90mg
Company Name: Biocon
Strength : 400 mg + 90 mg
Package: 28 tabs
Pack Type : Bottle
CIMIVIR L Contain Sofosbuvir and Ledipasvir For the treatment of Hepatitis C. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.
The hepatitis C virus is a bloodborne virus and the most common modes of infection are through unsafe injection practices, inadequate sterilization of medical equipment, and the transfusion of unscreened blood and blood products.
Globally, between 130–150 million people globally have chronic hepatitis C infection.
A significant number of those who are chronically infected will develop liver cirrhosis or liver cancer.
There is currently no vaccine for hepatitis C; however research in this area is ongoing.
The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:
injecting drug use through the sharing of injection equipment;
the reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and
the transfusion of unscreened blood and blood products.
Uses:- Treating chronic hepatitis C virus (HCV) infection in certain patients. Ledipasvir and sofosbuvir is a combination of 2 hepatitis C virus (HCV) antiviral agents. It reduces the amount of HCV in the body by preventing the spread of the HCV within the body.
Available other Brand : HEPCINAT LP, LEDIFOS, RESOF L, LEDVICLEAR, MYHEP LVIR, HEPCVIR L, , SOFOCURE L, NOVISOF L, LEDIHEP, SOFAB LP, LEDVICLEAR, SOFOCRUZ LP, SOFOKEM L